Rheumatic DiseaseInfo Center
Enbrel Biosimilar Gets Green Light
Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.
Cryotherapy a Cool Trend After All?
Whole-body cryotherapy may not be so cool after all, according to the US Food and Drug Administration (FDA).
Find A Prescription Treatment For Moderate or Severe RA
Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Learn About an FDA Approved Treatment for Rheumatoid Arthritis
New Treatment for Rare Genetic Condition
The US Food and Drug Administration (FDA) has approved a new treatment for a rare genetic disease.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
That Anti-Inflammatory Rx May Have an Extra Benefit
Medications used to treat conditions like psoriasis and rheumatoid arthritis may also be able to treat depression symptoms, a new study found.
Three Rare Diseases Get New Treatment Option
The US Food and Drug Administration (FDA) has approved a new treatment option for three rare diseases.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.